Zemaira
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Zemaira, covering 2015-01-19 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD) [Phase 4]